Vermillion Delisted from Nasdaq; Will Trade on Pink Sheets | GenomeWeb
NEW YORK (GenomeWeb News) – Vermillion said today that it has been delisted from the Nasdaq Capital Market as of this morning due to noncompliance with Nasdaq’s minimum requirements.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: comprehensive analysis of somatic mutations in breast cancer, and more.

A number of studies indicate that genes might influence political beliefs, Scientific American Mind reports.

Craig Venter's Human Longevity is deeply phenotyping individuals and capturing their genetic profiles to explore aging.

The San Francisco Business Times examines Verily's latest hires.